Season One of Surfing The NASH Tsunami

The Newer Diabetes Drugs and Patients with NASH

S2-E7 – The Newer Diabetes Drugs and Patients with NASH

Jörn Schattenberg and Fatty Liver Foundation President Wayne Eskridge join Louise and Roger to consider the current and future roles that GLP-1 receptor agonists like semaglutide and SGLT-2 inhibitors like Jardiance in treating NASH patients.

Season 2 Episode 1

COVID-19 and Fatty Liver: What We Know in 2021

Manal Abdelmalek joins the Surfers to discuss how recent COVID-19 news might affect Fatty Liver patients and what the medical profession and BioPharma companies can do to support patients better during this dangerous phase of the pandemic.

Episode 40 - Links Between NAFLD And Cardiovascular Disease

Links between NAFLD and Cardiovascular Disease

Dr Ian Rowe and Prof. Dr. Jörn M. Schattenberg joins the Surfers to explore the relationship between NAFLD and CVD in light of recent work questioning the strength of links between the two

COVID CHAOS: The 2nd Wave – Ep 39

Guest Ian Rowe and Kris Kowdley join the Surfers to discuss how the 2nd COVID wave and arrival of the vaccine are likely to affect patient treatment and clinical development

Subscribe for free. New podcasts Wednesday Evening / Thursday Morning.